
Russia has signed a deal with an Indian pharma firm to test and deliver 100 million doses of its controversial …

After sparking a wave of concern through industry and mainstream media with the news it had halted international studies investigating …

Albert Bourla, the CEO of Pfizer, has said that the company’s vaccine for COVID-19 could be used by the general …

Pascal Soriot, Chief Executive of AstraZeneca, said that the company’s vaccine could still be available this year, despite the clinical …

Pfizer-BioNTech announced Wednesday that preliminary preclinical data from mouse and macaque monkey models showed a strong immune response from its …

60,000 people across Britain may have been suffering from prolonged symptoms of coronavirus months after contracting the virus. This is …

Sanofi is halting clinical trials treating serious COVID-19 patients with its Kevzara drug after data on its efficacy proved inconclusive.The …

The top 10 news stories this week are focused on coronavirus vaccines and treatments, as China is set to move …

AstraZeneca has started a clinical trial of its antibody treatment designed to prevent and also treat symptoms of coronavirus. The …

China is set to move ahead with human testing of a potential coronavirus vaccine that has been created using insect …

Moderna continues to rise to meet the demands of the pandemic, signing a new deal with the US Government to …

President Putin has announced that Russia is the first country to grant regulatory approval for a COVID-19 vaccine. The final …

Novavax is partnering up with the Serum Institute of India Private Limited (SIIPL) in a licensing deal to development and …

New Phase 1/2 on Novavax’s COVID-19 vaccine candidate NVX‑CoV2373 has shown that the therapy generated “robust antibody responses” when used …

The Russian government is claiming it will start production of a viable coronavirus vaccine candidate next month and begin the …